The new GP contract for 2025/26 will see changes to the Additional Roles Reimbursement Scheme (ARRS) and Quality and Outcomes Framework (QOF).
While the full GP contract and primary care network (PCN) contract are yet to be published, some information has already been shared by NHS England and the British Medical Association (BMA).
The Pharmacist breaks down what we know so far, and what practice and PCN pharmacists need to know.
What will adding nurses and GPs to combined ARRS funding pot mean for pharmacists?
For 2025/26, there will not be a separate pot of funding for recruiting GPs through ARRS. Instead, there will be one pot of ARRS funding that PCNs can use for any role within the scheme, including pharmacists, GPs and, for the first time, practice nurses.
President of the Primary Care Association (PCPA) Dr Graham Stretch said he had noticed 'nervousness' among ARRS pharmacists worried their role might be at risk if a PCN chose to recruit a GP or nurse with that funding instead.
Dr Stretch advised pharmacists in that position: 'Make your presence felt, make sure that you're seen by the partners and by the clinical directors that [pharmacists] are such good value so they don't want to hire somebody else.'
In a recent survey by our sister titles Healthcare Leader and Pulse PCN, GPs ranked pharmacists as the most successful ARRS role.
And recent primary care workforce figures indicate that pharmacists continue to be the most hired ARRS role.
Will ARRS pharmacists see a pay increase from the GP contract uplift?
According to the BMA, the amount that each PCN can claim per ARRS clinical pharmacist working at band 7-8a will be uplifted to £66,972 in 2025/26.*
And for advanced practitioners working at band 8a, PCNs will be able to claim £73,334.
Meanwhile the reimbursable amount for pharmacy technicians will be uplifted to £43,352.
According to NHS England, these amounts are intended to be used towards the salaries and some on costs of these clinicians.
And Dr Stretch told The Pharmacist that it remained unclear whether practice pharmacists would see an uplift in their salaries, or whether these increases may be used to cover National Insurance Contribution rises.
He also noted that while the amount that could be claimed per role had increased, it was not yet clear whether there would be an uplift in the total amount of funding available through ARRS overall.
In previous years, when PCNs were allowed to spend more on staff salaries, they were not given any increase in overall funding to do so, which may impact how many or which ARRS staff they employ.
In a recent survey carried out by our sister title Pulse PCN, of 147 PCN respondents, some 55% said they had paid over 5% more than the ARRS allowances for their pharmacist, with 8% of those paying more than 20% above this.
Will the new GP contract change the work that PCN pharmacists do?
Other changes to the GP contract will see some QOF payment incentives removed, with the associated £100m in funding invested into the GP Global Sum, childhood immunisation payments and locum reimbursement rates.
Some of these QOF points will be redirected towards cardiovascular disease (CVD) prevention, with practices encouraged to reach higher thresholds across several indicators.
And on other QOF indicators, some technical changes have been made to reflect latest clinical practice.
With CVD thresholds increasing, Brendon Jiang, vice chair of the Royal Pharmaceutical Society (RPS) England Pharmacy Board, told The Pharmacist that general practice pharmacy teams had 'already played a key role in delivering against these indicators over the past year'.
'As thresholds increase, they will continue to support in identifying and optimising CVD prevention,' he added.
Read more from Mr Jiang on how pharmacists in his PCN are working with community heart failure nurses to upskill, improve patient care and tackle health inequalities.
*This article was updated on 27/03/25 to clarify the amount that each PCN can claim per ARRS clinical pharmacist working at band 7-8a will be uplifted to £66,972 in 2025/26.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.